ID27214A - Triazolopiridina untuk pengobatan gangguan trombosis - Google Patents
Triazolopiridina untuk pengobatan gangguan trombosisInfo
- Publication number
- ID27214A ID27214A IDW20010365A ID20010365A ID27214A ID 27214 A ID27214 A ID 27214A ID W20010365 A IDW20010365 A ID W20010365A ID 20010365 A ID20010365 A ID 20010365A ID 27214 A ID27214 A ID 27214A
- Authority
- ID
- Indonesia
- Prior art keywords
- triazolopiridina
- trombosis
- disorders
- treatment
- trombosis disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9423198P | 1998-07-27 | 1998-07-27 | |
| US09/354,032 US6303625B1 (en) | 1998-07-27 | 1999-07-15 | Triazolopyridines for the treatment of thrombosis disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27214A true ID27214A (id) | 2001-03-08 |
Family
ID=22243910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20010365A ID27214A (id) | 1998-07-27 | 1999-07-21 | Triazolopiridina untuk pengobatan gangguan trombosis |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6303625B1 (id) |
| EP (1) | EP1102766B1 (id) |
| JP (1) | JP2003527306A (id) |
| KR (1) | KR20010079576A (id) |
| CN (1) | CN1320125A (id) |
| AR (1) | AR019477A1 (id) |
| AT (1) | ATE263169T1 (id) |
| AU (1) | AU757512B2 (id) |
| BR (1) | BR9912556A (id) |
| CA (1) | CA2338654A1 (id) |
| CZ (1) | CZ2001347A3 (id) |
| DE (1) | DE69916073T2 (id) |
| ES (1) | ES2219042T3 (id) |
| HU (1) | HUP0103832A3 (id) |
| ID (1) | ID27214A (id) |
| MX (1) | MXPA01001099A (id) |
| NO (1) | NO20010456L (id) |
| PL (1) | PL345769A1 (id) |
| SK (1) | SK1342001A3 (id) |
| WO (1) | WO2000006570A1 (id) |
| ZA (1) | ZA200100783B (id) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306909B1 (en) | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| EE200200070A (et) * | 1999-08-13 | 2003-04-15 | Biogen, Inc. | Raku adhesiooni inhibiitorid |
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2002096424A1 (en) * | 2001-05-25 | 2002-12-05 | Queen's University At Kingston | Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| US20090215817A1 (en) * | 2004-08-18 | 2009-08-27 | Pfizer Inc | Novel Triazolopyridine Compounds for the Treatment of Inflammation |
| WO2006052962A2 (en) * | 2004-11-10 | 2006-05-18 | Janssen Pharmaceutica, N.V. | Bicyclic triazole a4 integrin inhibitors |
| US8686189B2 (en) * | 2005-09-16 | 2014-04-01 | Daiichi Sankyo Company, Limited | Optically active diamine derivative and process for producing the same |
| ATE542818T1 (de) * | 2006-10-11 | 2012-02-15 | Amgen Inc | Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung |
| US8685967B2 (en) * | 2009-04-07 | 2014-04-01 | Merck Sharp & Dohme Corp. | Substituted triazolopyridines and analogs thereof |
| US8871760B2 (en) * | 2009-09-21 | 2014-10-28 | Roche Palo Alto Llc | [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators |
| UY34329A (es) | 2011-09-15 | 2013-04-30 | Novartis Ag | Compuestos de triazolopiridina |
| US20160108039A1 (en) * | 2013-06-03 | 2016-04-21 | Bayer Pharma Aktiengesellschaft | Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic diseases |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| WO2024052684A1 (en) | 2022-09-09 | 2024-03-14 | MyricX Pharma Limited | Antibody drug conjugate comprising nmt inhibitor and its use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050525A (en) | 1960-12-14 | 1962-08-21 | John B Bicking | Certain derivatives of s-triazolo [4, 3-a]-pyridine |
| CN1118139A (zh) | 1993-02-22 | 1996-03-06 | 麦克公司 | 纤维蛋白原受体拮抗剂 |
| DE4326758A1 (de) * | 1993-08-10 | 1995-02-16 | Basf Ag | [1,3,4]Triazolo[1,5-a]pyridine |
| CA2134192A1 (en) | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
-
1999
- 1999-07-15 US US09/354,032 patent/US6303625B1/en not_active Expired - Lifetime
- 1999-07-21 MX MXPA01001099A patent/MXPA01001099A/es unknown
- 1999-07-21 CN CN99811380A patent/CN1320125A/zh active Pending
- 1999-07-21 PL PL99345769A patent/PL345769A1/xx not_active Application Discontinuation
- 1999-07-21 CA CA002338654A patent/CA2338654A1/en not_active Abandoned
- 1999-07-21 HU HU0103832A patent/HUP0103832A3/hu unknown
- 1999-07-21 JP JP2000562372A patent/JP2003527306A/ja active Pending
- 1999-07-21 BR BR9912556-0A patent/BR9912556A/pt not_active Application Discontinuation
- 1999-07-21 ES ES99937373T patent/ES2219042T3/es not_active Expired - Lifetime
- 1999-07-21 WO PCT/US1999/016572 patent/WO2000006570A1/en not_active Ceased
- 1999-07-21 AU AU52218/99A patent/AU757512B2/en not_active Ceased
- 1999-07-21 ID IDW20010365A patent/ID27214A/id unknown
- 1999-07-21 CZ CZ2001347A patent/CZ2001347A3/cs unknown
- 1999-07-21 AT AT99937373T patent/ATE263169T1/de not_active IP Right Cessation
- 1999-07-21 SK SK134-2001A patent/SK1342001A3/sk unknown
- 1999-07-21 DE DE69916073T patent/DE69916073T2/de not_active Expired - Fee Related
- 1999-07-21 EP EP99937373A patent/EP1102766B1/en not_active Expired - Lifetime
- 1999-07-21 KR KR1020017001183A patent/KR20010079576A/ko not_active Withdrawn
- 1999-07-26 AR ARP990103671A patent/AR019477A1/es unknown
-
2001
- 2001-01-26 ZA ZA200100783A patent/ZA200100783B/en unknown
- 2001-01-26 NO NO20010456A patent/NO20010456L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103832A3 (en) | 2002-12-28 |
| EP1102766A1 (en) | 2001-05-30 |
| CN1320125A (zh) | 2001-10-31 |
| WO2000006570A1 (en) | 2000-02-10 |
| CZ2001347A3 (cs) | 2001-12-12 |
| AR019477A1 (es) | 2002-02-20 |
| BR9912556A (pt) | 2002-01-15 |
| ATE263169T1 (de) | 2004-04-15 |
| ES2219042T3 (es) | 2004-11-16 |
| JP2003527306A (ja) | 2003-09-16 |
| US6303625B1 (en) | 2001-10-16 |
| CA2338654A1 (en) | 2000-02-10 |
| DE69916073D1 (de) | 2004-05-06 |
| MXPA01001099A (es) | 2002-04-24 |
| KR20010079576A (ko) | 2001-08-22 |
| HUP0103832A2 (hu) | 2002-04-29 |
| AU5221899A (en) | 2000-02-21 |
| EP1102766B1 (en) | 2004-03-31 |
| SK1342001A3 (en) | 2002-04-04 |
| NO20010456D0 (no) | 2001-01-26 |
| ZA200100783B (en) | 2002-01-28 |
| PL345769A1 (en) | 2002-01-02 |
| DE69916073T2 (de) | 2004-12-30 |
| NO20010456L (no) | 2001-03-26 |
| AU757512B2 (en) | 2003-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993051L (no) | Intranasale formuleringer for behandling av seksuelle forstyrrelser | |
| DE69936335D1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| NO20004688D0 (no) | Terapi ved østrogenassosierte lidelser | |
| ID30276A (id) | Metode untuk mengobati gangguan-gangguan seksual | |
| NO20001870L (no) | Ny fremgangsmÕte for behandling | |
| PT1077940E (pt) | 4-fenilpiperidinas novas para o tratamento de dermatoses pruriginosas | |
| NO20005884L (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| ID27191A (id) | Metode untuk pengobatan insomnia | |
| EE200200632A (et) | Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks | |
| NO20010456L (no) | Triazolopyridiner for behandling av trombose lidelser | |
| IS5951A (is) | 5HT1 mótlyf fyrir meðferð gegn þunglyndi | |
| NO20012106L (no) | Middel for behandling av forstyrrelser i benmetabolismen | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| NO20010390D0 (no) | Behandling av angstsykdommer | |
| PT1051172E (pt) | Metodo para tratamento da dpco | |
| AR026062A1 (es) | Tratamiento de desordenes oculares | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
| ID30458A (id) | Osanetan dalam pengobatan gangguan jiwa | |
| IL126681A0 (en) | Treatment of trauma-related conditions | |
| ID24922A (id) | Terapi kombinasi untuk pengobatan aids | |
| EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
| NO20006383D0 (no) | Fremgangsmåte for behandling | |
| DK82798A (da) | Treatment of GABA-uptake related disorders | |
| NO20012301D0 (no) | Ny fremgangsmåte for behandling |